(Senior)Medical Science Manager at Bristol-Myers Squibb

Beijing, China

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

PharmaceuticalIndustries

Requirements

Field-based role requiring minimum 60-70% time in the field with external customers (Thought Leaders and Healthcare Providers)
Ability to develop and maintain contacts with Thought Leaders (TL) and Healthcare Providers (HCP) within healthcare systems
Capability to engage in peer-to-peer scientific/clinical discussions on disease management, BMS products, and HEOR data in a fair and balanced way
Alignment with medical strategies and addressing stakeholder needs to ensure patient access, safe and appropriate use of BMS medicines
Physical ability to travel to visit customers, patients, or business partners and attend meetings as directed (essential for field-based role)
Senior-level expertise implied in Medical Science Manager role, focusing on trusted, agile partnerships delivering high-impact data and insights

Responsibilities

Embody BMS medical mission as a trusted, agile partner engaging in relevant dialogue
Deliver timely, high-impact data and insights to advance science, accelerate access, optimize medical practice, and drive appropriate adoption of BMS medicines
Develop and maintain contacts with Thought Leaders (TL) and Healthcare Providers (HCP)
Conduct scientific dialogues on disease management and BMS products, including HEOR data, aligned with medical strategies and stakeholder needs
Ensure patients have access to BMS medicines and promote their safe and appropriate use through peer-to-peer discussions

Skills

Medical Science Liaison

Thought Leader Engagement

Healthcare Provider Interactions

Scientific Exchange

HEOR

Disease Management

Stakeholder Management

Peer-to-Peer Discussions

Clinical Information

Field Medical

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free